Stocks
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -227.2% | -445.3% | -353.6% | -239.6% | -143.8% | -131.9% | |
| Changes by years, y/y, % | +105pp | -218pp | +92pp | +114pp | +96pp | |||
Nektar Therapeutics. EBITDA margin, %
Nektar Therapeutics. EBITDA margin, changes, pp
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -152.7% | -138.9% | -118.6% | -121.4% | -151.8% | -131.9% | |
| Changes by years, y/y, % | +294pp | +73pp | +20pp | +50pp | +1pp | |||
| Changes by quarters, q/q, % | +19pp | +14pp | +20pp | -3pp | -30pp | |||
